C.D.C. Panel Recommends Third Dose of Covid Vaccine for Immunocompromised

A day after the F.D.A. authorized third doses of the Pfizer-BioNTech and Moderna vaccines for some immunocompromised people, an independent expert panel advising the C.D.C. recommended the move.

WASHINGTON — An independent panel advising the Centers for Disease Control and Prevention on Friday recommended third doses of coronavirus vaccine for certain people with weakened immune systems, giving its support to the Food and Drug Administration’s authorization of the extra shots. The F.D.A. on Thursday cleared third doses for people with solid organ transplants and others with similarly weakened immune systems, who face a higher risk of severe bouts of Covid-19. After nearly three hours of presentations and discussion on Friday, the C.D.C. committee, made up of medical experts, voted unanimously to recommend third shots for people in the category who have already received the two-dose vaccines made by Pfizer-BioNTech or Moderna.